跳至主要内容
临床试验/NCT07347262
NCT07347262已完成不适用

A Pilot Study Evaluating the Use of a Novel Noninvasive Breath Test to Identify Patients at Risk for Developing Gestational Diabetes

Kaplan Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年12月18日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
The aim of our study is to evaluate the feasibility of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.

研究概览

简要总结

The aim of our study is to evaluate the feasibility, and diagnostic value of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.

详细描述

This prospective observational pilot study will include pregnant patients with a singleton fetus up to 33 weeks gestation.

Patients meeting the inclusion criteria who are willing to participate will be asked to drink 50 or 100 grams of glucose in 200 ml water (disposable plastic cup). The test will start at approximately 08:00 with no change in normal diet is needed prior to the GCT, or after an 8-14 hour overnight fast for the OGTT.

The test will be performed at the Maternal Fetal Medicine outpatient clinics, the Maternal Fetal Medicine unit for inpatients or at the patient's residence.

Samples collection

Glucose samples:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women
  • ages 18 to 45 years old
  • A singleton pregnancy
  • Confirmed gestational age by a documented first-trimester ultrasound.

排除标准

  • Patients below the age of 18 or above 45 years-old
  • Patients diagnosed with gestational or pre-gestational diabetes
  • Patients with multiple pregnancies or fetuses with congenital and/or chromosomal anomalies
  • Patients after a multifetal pregnancy reduction (spontaneous or iatrogenic)
  • Patients not having a sonographic dating during the first trimester of pregnancy
  • Patients with conditions or medications that affect glucose metabolism
  • Patients who will refuse to consent, or are not fit or able to read, understand, or sign an informed consent.

结局指标

主要结局

The aim of our study is to evaluate the feasibility of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.

时间窗: At the time of the glucose tolerance test (GCT/ OGTT)

We will assess feasibility via recruitment and test completion.

To evaluate the diagnostic value of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.

时间窗: At the time of the glucose tolerance test (GCT/ OGTT)

We will assess agreement between exogenous glucose oxidation (breath test) and blood glucose (OGTT).

次要结局

未报告次要终点

研究者

发起方
Kaplan Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maya Oberman

Attending physician

Kaplan Medical Center

研究点 (1)

Loading locations...

相似试验